open access

Vol 80, No 12 (2009)
ARTICLES
Get Citation

Assessment of relationship between cord blood cotinine levels and some factors of perinatal hypoxia

Elżbieta Baryła-Pankiewicz, Tomasz Elster, Maria Beata Czeszyńska, Halina Konefał, Diana Sochaczewska
Ginekol Pol 2009;80(12).

open access

Vol 80, No 12 (2009)
ARTICLES

Abstract

Abstract Objective: To determine the relationship between cord blood cotinine levels and some markers of perinatal hypoxia such as cord blood erythropoietin levels, parameters of umbilical arterial blood gas analysis and Apgar scores. Methods: 150 women with uncomplicated, healthy singleton pregnancies were assessed by means of a patient questionnaire. Neonates born by the examined pregnant women were divided into 3 groups according to recorded maternal smoking status – active smoking: n=51, passive smoking: n=49, non smoking: n=50. Immediately after birth umbilical venous (for cotinine and erythropoietin levels) and arterial blood (for pH, pO2, pCO2, BE) were collected. Results: Cotinine levels were significantly higher (p<0,00001) in active smoking group (Me=19,3 ng/ml) than in passive smoking (Me=0,75 ng/ml) and non smoking (Me=0,72ng/ml) ones. Cord blood erythropoietin, pH values and 1, 3 and 5-minute Apgar scores did not differ significantly between the study groups. No significant correlation between cotinine and erythropoietin, pH and Apgar scores results in all study material and in the compared groups was found. Conclusion: No correlation between cord blood cotinine and erythropoietin levels was detected. Cord blood cotinine concentration does not influence the condition of the newborn assessed by Apgar scores and umbilical arterial blood gas analysis.

Abstract

Abstract Objective: To determine the relationship between cord blood cotinine levels and some markers of perinatal hypoxia such as cord blood erythropoietin levels, parameters of umbilical arterial blood gas analysis and Apgar scores. Methods: 150 women with uncomplicated, healthy singleton pregnancies were assessed by means of a patient questionnaire. Neonates born by the examined pregnant women were divided into 3 groups according to recorded maternal smoking status – active smoking: n=51, passive smoking: n=49, non smoking: n=50. Immediately after birth umbilical venous (for cotinine and erythropoietin levels) and arterial blood (for pH, pO2, pCO2, BE) were collected. Results: Cotinine levels were significantly higher (p<0,00001) in active smoking group (Me=19,3 ng/ml) than in passive smoking (Me=0,75 ng/ml) and non smoking (Me=0,72ng/ml) ones. Cord blood erythropoietin, pH values and 1, 3 and 5-minute Apgar scores did not differ significantly between the study groups. No significant correlation between cotinine and erythropoietin, pH and Apgar scores results in all study material and in the compared groups was found. Conclusion: No correlation between cord blood cotinine and erythropoietin levels was detected. Cord blood cotinine concentration does not influence the condition of the newborn assessed by Apgar scores and umbilical arterial blood gas analysis.
Get Citation

Keywords

pH, cotinine, Erythropoietin, cord blood

About this article
Title

Assessment of relationship between cord blood cotinine levels and some factors of perinatal hypoxia

Journal

Ginekologia Polska

Issue

Vol 80, No 12 (2009)

Bibliographic record

Ginekol Pol 2009;80(12).

Keywords

pH
cotinine
Erythropoietin
cord blood

Authors

Elżbieta Baryła-Pankiewicz
Tomasz Elster
Maria Beata Czeszyńska
Halina Konefał
Diana Sochaczewska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl